Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

We create an individualized treatment plan for you, drawing upon our expertise in endoscopic and surgical treatments as well as medical therapies.

Clinical Trials and Research Studies

Phase 2

CA025-006 A Phase 2 Study of Cabiralizumab (BMS-986227 FPA008) Administered in Combination with Nivolumab (BMS-936558) with and without Chemotherapy in Patients with Advanced Pancreatic Cancer relating to BMS Compounds: BMS-986227 FPA008

Learn More

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 3

A Phase III Randomised Double Blind Placebo Controlled Multicentre Study of Maintenance Olaparib Monotherapy in Patients with gBRCA Mutated Metastatic Pancreatic Cancer whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy

Learn More

Phase 1/2

A Phase I/IIa Study of BMS-986205 Administered in Combination with Nivolumab (BMS-935558 anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors

Learn More